Sivandzade F., Cucullo L. 2021. Regenerative stem cell therapy for neurodegenerative diseases: An overview. Int. J. Mol. Sci. 22 (4), e2153.
Carp D.M., Liang Y. 2022. Universal or personalized mesenchymal stem cell therapies: Impact of age, sex, and biological source. Cells. 11 (13), e2077.
Goncalves K., Przyborski S. 2018. The utility of stem cells for neural regeneration. Brain Neurosci. Adv. 2 (2), e239821281881807
Behrstock S., Ebert A.D., Klein S., Schmitt M., Moore J.M., Svendsen C.N. 2008. Lesion-induced increase in survival and migration of human neural progenitor cells releasing GDNF. Cell Transplant. 17 (7), 753–762.
Blurton-Jones M., Kitazawa M., Martinez-Coria H., Castello N.A., Müller F.J., Loring J.F., Yamasaki T.R., Poon W.W., Green K.N., LaFerla F.M. 2009. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc. Natl. Acad. Sci. USA. 106 (32), 13594–13599.
Article CAS PubMed PubMed Central Google Scholar
Chaplygina A.V., Zhdanova D.Y., Kovalev V.I., Poltavtseva R.A., Medvinskaya N.I., Bobkova N.V. 2022. Cell therapy as a way to correct impaired neurogenesis in the adult brain in a model of Alzheimer’s disease. J. Evol. Biochem. Physiol. 58 (1), 117–137.
Kim S., Chang K.A., Kim J.A., Park H.G., Ra J.C., Kim H.S., Suh Y.H. 2012. The preventive and therapeutic effects of intravenous human adipose-derived stem cells in Alzheimer’s disease mice. PLoS One. 7 (9), e45757.
Article CAS PubMed PubMed Central Google Scholar
Bruno S., Kholia S., Deregibus M.C., Camussi G. 2019. The role of extracellular vesicles as paracrine effectors in stem cell-based therapies. Adv. Exp. Med. Biol. 1201, 175–193.
Article CAS PubMed Google Scholar
Yin K., Wang S., Zhao R.C. 2019. Exosomes from mesenchymal stem/stromal cells: A new therapeutic paradigm. Biomark. Res. 7, 8.
Article PubMed PubMed Central Google Scholar
Joyce N., Annett G., Wirthlin L., Olson S., Bauer G., Nolta J.A. 2010. Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen. Med. 5 (6), 933–946.
Xin D., Li T., Chu X., Ke H., Liu D., Wang Z. 2021. MSCs-extracellular vesicles attenuated neuroinflammation, synapse damage and microglial phagocytosis after hypoxia-ischemia injury by preventing osteopontin expression. Pharmacol. Res. 164, e105322.
Nair S., Rocha-Ferreira E., Fleiss B., Nijboer C.H., Gressens P, Mallard C, Hagberg H. 2021. Neuroprotection offered by mesenchymal stem cells in perinatal brain injury: Role of mitochondria, inflammation, and reactive oxygen species. J. Neurochem. 158 (1), 59–73.
Article CAS PubMed PubMed Central Google Scholar
Kim D.H., Lee D., Lim H., Choi S.J., Oh W., Yang Y.S., Chang J.H., Jeon H.B. 2018. Effect of growth differentiation factor-15 secreted by human umbilical cord blood-derived mesenchymal stem cells on amyloid beta levels in in vitro and in vivo models of Alzheimer’s disease. Biochem. Biophys. Res. Commun. 504 (4), 933–940.
Article CAS PubMed Google Scholar
Spees J.L., Lee R.H., Gregory C.A. 2016. Mechanisms of mesenchymal stem/stromal cell function. Stem Cell Res. Ther. 7 (1), 125.
Article PubMed PubMed Central Google Scholar
Ramkisoensing A.A., Pijnappels D.A., Swildens J., Goumans M.J., Fibbe W.E., Schalij M.J., de Vries A.A.F., Atsma D.E. 2012. Gap junctional coupling with cardiomyocytes is necessary but not sufficient for cardiomyogenic differentiation of cocultured human mesenchymal stem cells. Stem Cells. 30 (6), 1236–1245.
Article CAS PubMed Google Scholar
Matuskova M., Hlubinova K., Pastorakova A., Hunakova L., Altanerova V., Altaner C., Kucerova L. 2010. HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells. Cancer Lett. 290 (1), 58–67.
Article CAS PubMed Google Scholar
Kikuchi-Taura A., Okinaka Y., Saino O., Takeuchi Y., Ogawa Y., Kimura T., Gul S., Claussen C., Boltze J., Taguchi A. 2021. Gap junction-mediated cell-cell interaction between transplanted mesenchymal stem cells and vascular endothelium in stroke. Stem Cells. 39 (7), 904–912.
Article CAS PubMed Google Scholar
Bobkova N.V., Poltavtseva R.A., Samokhin A.N., Sukhikh G.T. 2013. Therapeutic effect of mesenchymal multipotent stromal cells on memory in animals with Alzheimer-type neurodegeneration. Bull. Exp. Biol. Med. 156 (1), 119–121.
Article CAS PubMed Google Scholar
Poltavtseva R.A., Samokhin A.N., Bobkova N.V., Alexandrova M.A., Sukhikh G.T. 2020. Effect of transplantation of neural stem and progenitor cells on memory in animals with Alzheimer’s type neurodegeneration. Bull. Exp. Biol. Med. 168 (4), 589–596.
Article CAS PubMed Google Scholar
Skok M. 2021. Mesenchymal stem cells as a potential therapeutic tool to cure cognitive impairment caused by neuroinflammation. World J. Stem Cells. 13 (8),1072–1083.
Article PubMed PubMed Central Google Scholar
Yun H.M., Kim H.S., Park K.R., Shin J.M., Kang A.R., il Lee K., Song S., Kim Y.B., Han S.B., Chung H.M., Hong J.T. 2013. Placenta-derived mesenchymal stem cells improve memory dysfunction in an Aβ1-42-infused mouse model of Alzheimer’s disease. Cell Death Dis. 4 (12), e958.
Article CAS PubMed PubMed Central Google Scholar
Bagheri-Mohammadi S. 2021. Microglia in Alzheimer’s disease: The role of stem cell-microglia interaction in brain homeostasis. Neurochem. Res. 46 (2), 141–148.
Article CAS PubMed Google Scholar
Qin C., Lu Y., Wang K., Bai L., Shi G., Huang Y., Li Y. 2020. Transplantation of bone marrow mesenchymal stem cells improves cognitive deficits and alleviates neuropathology in animal models of Alzheimer’s disease: A meta-analytic review on potential mechanisms. Transl. Neurodegener. 9 (1), 20.
Article PubMed PubMed Central Google Scholar
Yang H., Xie Z., Wei L., Yang H., Yang S., Zhu Z., Wang P., Zhao C., Bi J. 2013. Human umbilical cord mesenchymal stem cell-derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an AβPP/PS1 transgenic mouse model. Stem Cell Res. Ther. 4 (4), 76.
Article CAS PubMed PubMed Central Google Scholar
Hernández A.E., García E. 2021. Mesenchymal stem cell therapy for Alzheimer’s disease. Stem Cells Int. 2021, e7834421.
de Godoy M.A., Saraiva L.M., de Carvalho L.R.P., Vasconcelos-Dos-Santos A., Beiral H.J.V., Ramos A.B., Silva LR.P., Leal R.B., Monteiro V.H.S., Braga C.V., de Araujo-Silva C.A., Sinis L.C., Bodart-Santos V., Kasai-Brunswick T.H., Alcantara C.L., Lima A.P.C.A., da Cunha-E Silva N.L., Galina A., Vieyra A., De Felice F.G., Mendez-Otero R., Ferreira S.T. 2018. Mesenchymal stem cells and cell-derived extracellular vesicles protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid-β oligomers. J. Biol. Chem. 293 (6), 1957–1975.
Article CAS PubMed Google Scholar
Bobkova N.V., Lyabin D.N., Medvinskaya N.I., Samokhin A.N., Nekrasov P.V., Nesterova I.V., Aleksandrova I.Y., Tatarnikova O.G., Bobylev A.G., Vikhlyantsev I.M., Kukharsky M.S., Ustyugov A.A., Polyakov D.N., Eliseeva I.A., Kretov D.A., Guryanov S.G., Ovchinnikov L.P. 2015. The Y-box binding protein 1 suppresses Alzheimer’s disease progression in two animal models. PLoS One. 10 (9), e0138867.
Article CAS PubMed PubMed Central Google Scholar
Evgenev M., Bobkova N., Krasnov G., Garbuz D., Funikov S., Kudryavtseva A., Kulikov A., Samokhin A., Maltsev A., Nesterova I. 2019. The effect of human HSP70 administration on a mouse model of Alzheimer’s disease strongly depends on transgenicity and age. J. Alzheimer’s Dis. 67, 1391–1404.
Miao X., Wu Y., Wang Y., Zhu X., Yin H., He Y., Li C., Liu Y., Lu X., Chen Y., Shen R., Xu X., He S. 2016. Y-box-binding protein-1 (YB-1) promotes cell proliferation, adhesion and drug resistance in diffuse large B-cell lymphoma. Exp. Cell Res. 346 (2), 157–166.
Article CAS PubMed Google Scholar
Xie F., Zhan R., Yan L-C., Gong J-B., Zhao Y., Ma J., Qian L-J. 2016. Diet-induced elevation of circulating HSP70 may trigger cell adhesion and promote the development of atherosclerosis in rats. Cell Stress Chaperones. 21 (5), 907–914.
Article CAS PubMed PubMed Central Google Scholar
Galipeau J., Krampera M., Barrett J., Dazzi F., Deans R.J., DeBruijn J., Dominici M., Fibbe W.E., Gee A.P., Gimble J.M., Hematti P., Koh M.B., LeBlanc K., Martin I., McNiece I.K., Mendicino M., Oh S., Ortiz L., Phinney D.G., Planat V., Shi Y., Stroncek D.F., Viswanathan S., Weiss D.J., Sensebe L. 2016. International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. Cytotherapy. 18 (2), 151–159.
Article CAS PubMed Google Scholar
Wang Y., Su J., Fu D., Wang Y., Chen Y., Chen R., Qin G., Zuo J., Yue D. 2018. The role of YB1 in renal cell carcinoma cell adhesion. Int. J. Med. Sci. 15, 1304–1311.
Article CAS PubMed PubMed Central Google Scholar
Kollar K., Cook M.M., Atkinson K., Brooke G. 2009. Molecular mechanisms involved in mesenchymal stem cell migration to the site of acute myocardial infarction. Int. J. Cell Biol. 2009, e904682.
Tang B., Li X., Liu Y., Chen X., Li X., Chu Y., Zhu H., Liu W., Xu F., Zhou F., Zhang Y. 2018. The therapeutic effect of ICAM-1-overexpressing mesenchymal stem cells on acute Graft-Versus-Host disease. Cell. Physiol. Biochem. 46 (6), 2624–2635.https://doi.org/10.1159/000489689
留言 (0)